A Software Bill of Materials acts as a critical ingredient list that allows manufacturers to
BullFrog AI is analyzing neuropsychiatric multi-omic data to identify novel targets for major
The nomination of ISM9546 marks a significant milestone for generative artificial intelligence, demonstrating its capacity to solve multi-parameter optimization challenges in complex autoimmune research. For decades, the pharmaceutical industry has grappled with the high failure rates of
The recent events at the Irkutsk Anti-Plague Research Institute demonstrate the significant challenges of managing public perception during a potential highly virulent disease outbreak. When Darya Shipilova, a 27-year-old laboratory specialist, passed away on October 2, the localized incident
By mimicking the bioelectric environment of living bone, this new composite material encourages the
The movement toward off-the-shelf immunotherapy is solving the scalability issues that have long
The partnership between Eli Lilly and NVIDIA to build a supercomputer capable of running trillions of molecular simulations is a signal that biopharma’s approach to drug discovery is changing at a s…
The move from research-level discovery to established clinical use is a critical juncture that
The biopharma playbook is being actively rewritten. After years of chasing breakthrough science at
In 2026, boards and customers are asking a direct question: can promising science be turned into
The pharmaceutical sector is entering a decisive phase as obesity therapeutics gain more ground as
The history of oncology was fundamentally rewritten when researchers moved away from the blunt-force approach of traditional chemotherapy toward the precision of molecularly targeted agents. This transition allowed for a shift in the standard of care, where physicians no longer simply attacked all
Blocking the movement of misfolded alpha-synuclein through the cerebrospinal fluid could
Future efforts will focus on scaling the model across multiple institutions to enhance its
